Science gone translational: the OX40 agonist story

Por Weinberg, Andrew D., Morris, Nicholas P., Kovacsovics-Bankowski, Magdalena, Urba, Walter J., Curti, Brendan D.
Publicado em 2011

Development and Characterization of Recombinant Human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain

Por Morris, Nicholas P., Peters, Carmen, Montler, Ryan, Hu, Hong-Ming, Curti, Brendan D., Urba, Walter J., Weinberg, Andrew D.
Publicado em 2007

Mutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia

Por Chen, Yanwen, Molloy, Sean S., Thomas, Laurel, Gambee, Jay, Bächinger, Hans Peter, Ferguson, Betsy, Zonana, Jonathan, Thomas, Gary, Morris, Nicholas P.
Publicado em 2001

Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression

Por Yu, Guangjie, Li, Yuhuan, Cui, Zhihua, Morris, Nicholas P., Weinberg, Andrew D., Fox, Bernard A., Urba, Walter J., Wang, Lixin, Hu, Hong-Ming
Publicado no Sci Rep (2016)

Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein

Por Oberst, Michael D., Augé, Catherine, Morris, Chad, Kentner, Stacy, Mulgrew, Kathy, McGlinchey, Kelly, Hair, James, Hanabuchi, Shino, Du, Qun, Damschroder, Melissa, Feng, Hui, Eck, Steven, Buss, Nicholas, de Haan, Lolke, Pierce, Andrew J., Park, Haesun, Sylwester, Andrew, Axthelm, Michael K., Picker, Louis, Morris, Nicholas P., Weinberg, Andrew, Hammond, Scott A.
Publicado no Mol Cancer Ther (2018)